TD Asset Management Inc Has $137.69 Million Holdings in Agilent Technologies, Inc. (NYSE:A)

Key Points

• TD Asset Management Inc reduced its holdings in Agilent Technologies by 13.4%, selling 182,711 shares, leaving it with approximately 1,177,043 shares valued at $137.69 million.
• Agilent Technologies reported $1.31 EPS for the quarter, beating estimates, with a 6% year-over-year revenue growth to $1.67 billion.
• The company declared a quarterly dividend of $0.248 per share, representing an annualized yield of 0.83% and a payout ratio of 24.44%.

TD Asset Management Inc reduced its holdings in shares of Agilent Technologies, Inc. (NYSE:A - Free Report) by 13.4% in the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 1,177,043 shares of the medical research company's stock after selling 182,711 shares during the quarter. TD Asset Management Inc owned 0.41% of Agilent Technologies worth $137,690,000 at the end of the most recent quarter.

Other institutional investors also recently bought and sold shares of the company. Norges Bank acquired a new stake in Agilent Technologies in the fourth quarter valued at $456,963,000. GAMMA Investing LLC grew its position in shares of Agilent Technologies by 15,648.1% during the first quarter. GAMMA Investing LLC now owns 627,247 shares of the medical research company's stock worth $73,375,000 after acquiring an additional 623,264 shares during the last quarter. Two Sigma Investments LP grew its position in shares of Agilent Technologies by 345.9% during the fourth quarter. Two Sigma Investments LP now owns 769,897 shares of the medical research company's stock worth $103,428,000 after acquiring an additional 597,249 shares during the last quarter. Iron Triangle Partners LP bought a new position in shares of Agilent Technologies during the fourth quarter worth about $80,110,000. Finally, Marshall Wace LLP grew its position in shares of Agilent Technologies by 280.3% during the fourth quarter. Marshall Wace LLP now owns 806,895 shares of the medical research company's stock worth $108,398,000 after acquiring an additional 594,744 shares during the last quarter.

Insider Activity

In other news, CEO Padraig Mcdonnell sold 1,508 shares of the business's stock in a transaction dated Tuesday, July 1st. The stock was sold at an average price of $117.44, for a total transaction of $177,099.52. Following the completion of the transaction, the chief executive officer directly owned 37,448 shares in the company, valued at approximately $4,397,893.12. The trade was a 3.87% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink.

Agilent Technologies Trading Down 0.7%

A stock traded down $0.81 during midday trading on Wednesday, reaching $119.03. The stock had a trading volume of 175,859 shares, compared to its average volume of 2,023,978. The business has a fifty day simple moving average of $116.70 and a two-hundred day simple moving average of $121.20. The company has a quick ratio of 1.60, a current ratio of 2.09 and a debt-to-equity ratio of 0.55. The firm has a market cap of $33.81 billion, a price-to-earnings ratio of 29.40, a PEG ratio of 3.63 and a beta of 1.23. Agilent Technologies, Inc. has a twelve month low of $96.43 and a twelve month high of $153.84.

Agilent Technologies (NYSE:A - Get Free Report) last announced its quarterly earnings data on Wednesday, May 28th. The medical research company reported $1.31 EPS for the quarter, topping analysts' consensus estimates of $1.26 by $0.05. The firm had revenue of $1.67 billion during the quarter, compared to analyst estimates of $1.63 billion. Agilent Technologies had a return on equity of 25.92% and a net margin of 17.59%. The company's revenue was up 6.0% on a year-over-year basis. During the same period last year, the company earned $1.22 earnings per share. As a group, research analysts expect that Agilent Technologies, Inc. will post 5.58 EPS for the current fiscal year.

Agilent Technologies Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Wednesday, July 23rd. Investors of record on Tuesday, July 1st were given a $0.248 dividend. The ex-dividend date of this dividend was Tuesday, July 1st. This represents a $0.99 dividend on an annualized basis and a yield of 0.83%. Agilent Technologies's payout ratio is 24.44%.

Analysts Set New Price Targets

A number of equities analysts recently issued reports on the stock. UBS Group decreased their target price on shares of Agilent Technologies from $150.00 to $130.00 and set a "neutral" rating for the company in a research report on Thursday, May 29th. JPMorgan Chase & Co. reduced their price objective on shares of Agilent Technologies from $160.00 to $155.00 and set an "overweight" rating for the company in a research report on Thursday, May 29th. TD Cowen upped their price objective on shares of Agilent Technologies to $150.00 and gave the company a "buy" rating in a research note on Thursday, May 29th. Leerink Partners upped their price objective on shares of Agilent Technologies to $135.00 and gave the company a "buy" rating in a research note on Friday, May 30th. Finally, Evercore ISI upped their price objective on shares of Agilent Technologies from $125.00 to $130.00 and gave the company an "in-line" rating in a research note on Tuesday, July 8th. Six equities research analysts have rated the stock with a hold rating and eight have given a buy rating to the company. According to data from MarketBeat, Agilent Technologies presently has a consensus rating of "Moderate Buy" and an average target price of $139.77.

Agilent Technologies Company Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.